183 related articles for article (PubMed ID: 16595635)
21. Mechanistic peculiarities of activation-induced mobilization of cytotoxic effector proteins in human T cells.
Lettau M; Armbrust F; Dohmen K; Drews L; Poch T; Dietz M; Kabelitz D; Janssen O
Int Immunol; 2018 Apr; 30(5):215-228. PubMed ID: 29373679
[TBL] [Abstract][Full Text] [Related]
22. Platycodin D-induced apoptosis through nuclear factor-kappaB activation in immortalized keratinocytes.
Ahn KS; Hahn BS; Kwack K; Lee EB; Kim YS
Eur J Pharmacol; 2006 May; 537(1-3):1-11. PubMed ID: 16631160
[TBL] [Abstract][Full Text] [Related]
23. Engagement of CD44 up-regulates Fas ligand expression on T cells leading to activation-induced cell death.
Nakano K; Saito K; Mine S; Matsushita S; Tanaka Y
Apoptosis; 2007 Jan; 12(1):45-54. PubMed ID: 17136494
[TBL] [Abstract][Full Text] [Related]
24. CD2AP is indispensable to multistep cytotoxic process by NK cells.
Ma Y; Yang H; Qi J; Liu D; Xiong P; Xu Y; Feng W; Zheng G; Li P; Fang M; Tan Z; Zheng F; Gong F
Mol Immunol; 2010 Feb; 47(5):1074-82. PubMed ID: 19945749
[TBL] [Abstract][Full Text] [Related]
25. A proteomic screen reveals novel Fas ligand interacting proteins within nervous system Schwann cells.
Thornhill PB; Cohn JB; Drury G; Stanford WL; Bernstein A; Desbarats J
FEBS Lett; 2007 Sep; 581(23):4455-62. PubMed ID: 17761170
[TBL] [Abstract][Full Text] [Related]
26. Fas ligand in the uterus of the non-pregnant mouse induces apoptosis of CD4+ T cells.
Imarai M; Varela-Nallar L; Figueroa-Gaete C; González P; Valdés D; Velásquez L; Cárdenas H; Maisey K
J Reprod Immunol; 2005 Jun; 66(1):13-32. PubMed ID: 15949559
[TBL] [Abstract][Full Text] [Related]
27. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
Greil R; Egle A; Villunger A
Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038
[TBL] [Abstract][Full Text] [Related]
28. Secretory lysosomes and their cargo in T and NK cells.
Lettau M; Schmidt H; Kabelitz D; Janssen O
Immunol Lett; 2007 Jan; 108(1):10-9. PubMed ID: 17097742
[TBL] [Abstract][Full Text] [Related]
29. The dual role of Fas-ligand as an injury effector and defense strategy in diabetes and islet transplantation.
Pearl-Yafe M; Yolcu ES; Yaniv I; Stein J; Shirwan H; Askenasy N
Bioessays; 2006 Feb; 28(2):211-22. PubMed ID: 16435302
[TBL] [Abstract][Full Text] [Related]
30. Critical roles for JNK, c-Jun, and Fas/FasL-Signaling in vitamin E analog-induced apoptosis in human prostate cancer cells.
Jia L; Yu W; Wang P; Li J; Sanders BG; Kline K
Prostate; 2008 Mar; 68(4):427-41. PubMed ID: 18196534
[TBL] [Abstract][Full Text] [Related]
31. Regulation of FasL expression: a SH3 domain containing protein family involved in the lysosomal association of FasL.
Qian J; Chen W; Lettau M; Podda G; Zörnig M; Kabelitz D; Janssen O
Cell Signal; 2006 Aug; 18(8):1327-37. PubMed ID: 16318909
[TBL] [Abstract][Full Text] [Related]
32. Role of endogenous Fas (CD95/Apo-1) ligand in balloon-induced apoptosis, inflammation, and neointima formation.
Matter CM; Chadjichristos CE; Meier P; von Lukowicz T; Lohmann C; Schuler PK; Zhang D; Odermatt B; Hofmann E; Brunner T; Kwak BR; Lüscher TF
Circulation; 2006 Apr; 113(15):1879-87. PubMed ID: 16606788
[TBL] [Abstract][Full Text] [Related]
33. CTL secretory lysosomes: biogenesis and secretion of a harmful organelle.
Bossi G; Griffiths GM
Semin Immunol; 2005 Feb; 17(1):87-94. PubMed ID: 15582491
[TBL] [Abstract][Full Text] [Related]
34. Expression of FasL by tumor cells does not abrogate anti-tumor CTL function.
Lee SH; Bar-Haim E; Goldberger O; Reich-Zeliger S; Vadai E; Tzehoval E; Eisenbach L
Immunol Lett; 2004 Feb; 91(2-3):119-26. PubMed ID: 15019279
[TBL] [Abstract][Full Text] [Related]
35. Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells.
Bossi G; Griffiths GM
Nat Med; 1999 Jan; 5(1):90-6. PubMed ID: 9883845
[TBL] [Abstract][Full Text] [Related]
36. Differential role of tyrosine phosphorylation in the induction of apoptosis in T cell clones via CD95 or the TCR/CD3-complex.
Oberg HH; Lengl-Janssen B; Robertson MJ; Kabelitz D; Janssen O
Cell Death Differ; 1997 Jul; 4(5):403-12. PubMed ID: 16465259
[TBL] [Abstract][Full Text] [Related]
37. Dissociation of Fas-mediated cytotoxicity and FasL expression in a cytotoxic CD4+ T-cell clone. Comparative analysis of Fas-mediated cytotoxicity between a T-hybridoma and a T-cell clone.
Kaneda R; Iwabuchi K; Onoé K
Immunol Lett; 1997 Jan; 55(1):53-60. PubMed ID: 9093882
[TBL] [Abstract][Full Text] [Related]
38. Specificity determinants of a novel Nck interaction with the juxtamembrane domain of the epidermal growth factor receptor.
Hake MJ; Choowongkomon K; Kostenko O; Carlin CR; Sönnichsen FD
Biochemistry; 2008 Mar; 47(10):3096-108. PubMed ID: 18269246
[TBL] [Abstract][Full Text] [Related]
39. Cell cycle regulation by FasL and Apo2L/TRAIL in human T-cell blasts. Implications for autoimmune lymphoproliferative syndromes.
Bosque A; Aguiló JI; del Rey M; Paz-Artal E; Allende LM; Naval J; Anel A
J Leukoc Biol; 2008 Aug; 84(2):488-98. PubMed ID: 18483205
[TBL] [Abstract][Full Text] [Related]
40. The Fas death pathway controls coordinated expansions of type 1 CD8 and type 2 CD4 T cells in Trypanosoma cruzi infection.
Guillermo LV; Silva EM; Ribeiro-Gomes FL; De Meis J; Pereira WF; Yagita H; DosReis GA; Lopes MF
J Leukoc Biol; 2007 Apr; 81(4):942-51. PubMed ID: 17261545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
